Results 111 to 120 of about 8,876 (157)

Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications. [PDF]

Curr Ther Res Clin Exp
Yu J, Argon S, Owens K, Wang Y, Ragueneau-Majlessi I.   +4 more
europepmc   +1 more source

Drug-drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors. [PDF]

Expert Rev Clin Pharmacol
Stromatt JC, Chowdhury AT, Huang KM, Hu S, Sparreboom A, Baker SD, Eisenmann ED.   +6 more
europepmc   +1 more source

An Investigational Study on the Role of ADME Agents' Genetic Variation on DD217 Pharmacokinetics and Safety Profile. [PDF]

Pharmaceuticals (Basel)
Sychev DA, Abdullaev SP, Rudik AV, Dmitriev AV, Tuchkova SN, Denisenko NP, Makarov DS, Mirzaev KB.   +7 more
europepmc   +1 more source

Molecular Ancestry Across Allelic Variants of <i>SLC22A1</i>, <i>SLC22A2</i>, <i>SLC22A3</i>, <i>ABCB1</i>, <i>CYP2C8</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Mexican-Mestizo DMT2 Patients. [PDF]

Biomedicines
Ortega-Ayala A, de la Cruz CG, Dorado P, Rodrigues-Soares F, Castillo-Nájera F, LLerena A, Molina-Guarneros J.   +6 more
europepmc   +1 more source

PP33 Functional characterization of CYP2C8 promoter polymorphisms

European Journal of Cancer Supplements, 2009
openaire   +1 more source

Prevalence of substances with OATP1B1 inhibitory properties in individual case safety reports of suspected statin-associated myopathy - an analysis of Swiss pharmacovigilance data. [PDF]

Eur J Clin Pharmacol
Stäuble CK, Toma V, Stammschulte T, Allemann SS, Meyer Zu Schwabedissen HE.   +4 more
europepmc   +1 more source

Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol
Jaiswal S, Patel NK, Jones HM, McFeely S, Faison SL, Tippin T, Naderer O.   +6 more
europepmc   +1 more source

Metabolism of the Isoflavone Derivative Structural Isomers ACF-02 and ACF-03 in Human Liver Microsomes. [PDF]

Pharmaceutics
Liang Z, Kim EH, Kim GY, Choi JH, Seo HJ, Liu KH, Cho M.   +6 more
europepmc   +1 more source

Evaluation of the Pharmacokinetics, Disposition, and Metabolism of Miricorilant, a Novel Glucocorticoid Receptor Modulator for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in Nonclinical and Clinical Studies. [PDF]

J Clin Pharmacol
Hunt HJ, Donaldson KM, Kunta JR, Custodio JM.   +3 more
europepmc   +1 more source

Exploring the diagnostic and prognostic potential of LCFAs' metabolic and biosynthetic pathways in glioblastoma multiforme using a bioinformatics approach. [PDF]

Res Pharm Sci
Heydarian A, Yazdani B, Sirous H.
europepmc   +1 more source